Searched for
PHARMEASY OPERATING PROFIT
FirstCry, Slice’s FY26 numbers; Nilekani’s Fundamentum eyes deeptech pushFirstCry parent cut its losses in the March quarter on tightened costs. This and more in today's ETtech Top 5.- PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...
- Tata 1mg’s FY24 operating revenue up 21% to Rs 1,968 croreTata 1mg’s net loss plummeted to Rs 313 crore from Rs 1,255 crore in the previous financial year. Over 80% of the company’s operating reven...
- PharmEasy’s FY23 operating revenue up 16% to Rs 6,644 crore; net loss widens 30%PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...
- 1mg overtakes PharmEasy in market share in top order changeTata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...
- PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsPai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...
- Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanMumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021
- PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...
- Apple India stores post record sales; PharmEasy breaches loan covenant; and Amazon’s ten-year India rideWe are already in June, the year is racing past. Hope you have an interesting summer planned ahead. In April, Apple opened two company-owne...
- Scoop: PharmEasy valuation halved to $2.8 billion, logs ebitda profitability; Paytm’s loan biz decodedOnline pharmacy PharmEasy recorded a positive ebitda of around Rs 14 crore, which means it is operationally profitable, even as one of its ...
- PharmEasy logs first ebitda profit of Rs 14 crore in April, restarts funding talksThe epharmacy held discussions with CDPQ, ADQ; convertible notes are also being discussed amid valuation corrections and markdowns.
- In 2022, etailers trumped offline stores in smartphone shipments; PharmEasy rules out Thyrocare saleThe calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing...
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
- PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
- FirstCry plans $1 billion IPO, may seek Sebi nod next monthFirstCry turned profitable in fiscal year 2021, as per recent regulatory filings, clocking a net profit of nearly Rs 216 crore compared wit...
- Buy Thyrocare Technologies, target price Rs 1310: HDFC SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5758.02 Crore) operating in Hos...
- Thyrocare set for fast track with PharmEasyThyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...
- Medlife acquires Myra to take ePharma service to 22 citiesBengaluru startup’s acquisition indicates early signs of consolidation in the sector
- PharmEasy raises Rs 111 crore in Series-B roundThe funding indicates continued interest in the online pharmacy segment despite a reported dip in the total investment secured by startups ...
Load More
